Recently, Cf-mtDNA has emerged as a promising non-invasive diagnostic indicator of ongoing cellular damage and mortality, providing insight into the pathological mechanisms of neurodegenerative disorders, including Parkinson’s disease (PD) and Alzheimer’s disease (AD) [14]. The gene discussed is CFTR; the disease is Parkinson disease.